When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has been awarded a share of the £3 million ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...

Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...

There are many ways to take medication, but inhaled treatments ... used in the machine. If you see a pulmonologist or another respiratory specialist for asthma, cystic fibrosis, or another chronic ...

Proteins are like tiny machines in our bodies ... such as Alzheimer's disease, cystic fibrosis, cancers and more. In Alzheimer's, misfolded proteins mold into toxic plaques that disrupt neuronal ...

Learn about cystic fibrosis, a genetic disorder that ... We were able to negotiate a deal so that I was doing more treatments than I had been, but I wasn’t just sitting at home hooked up to machines.” ...

Read about the top 15 political, economic, social, environmental, technology and industry trends that will shape 2025 and ...

Hydreight Technologies Inc. ("Hydreight" or the "Company") , a rapidly growing mobile clinical network and medical platform and VSDHOne, its innovative telehealth and e-commerce platform developed in ...

CMTX-101 is under clinical development by Clarametyx Biosciences and currently in Phase II for Cystic Fibrosis. According to GlobalData ... CMTX-101 is under development for the treatment of hospital ...

SP-101 is under development for the treatment of cystic fibrosis. The therapeutic candidate is formulated ... This is based on a combination of machine learning and a proprietary algorithm to process ...

If you receive a denial letter from your insurer, don’t appeal the decision before seeking legal advice, says a leading ...